Sickle Cell Foundation of Georgia, Inc. Market Research Report

Background

Overview

The Sickle Cell Foundation of Georgia, Inc. (SCFG) is a nonprofit organization established on December 27, 1971, by Drs. Nelson McGhee and Delutha H. King, Jr., in response to the high incidence of sickle cell disease (SCD) among newborns. As of December 27, 2023, SCFG celebrated its 52nd anniversary.

Mission and Vision

Mission: To engage, educate, and energize the community to improve the quality of life for people affected by Sickle Cell Disease.

Vision: To empower individuals to "Live Well with Sickle Cell."

Primary Area of Focus

SCFG is dedicated to enhancing the quality of life for individuals and families in Georgia impacted by sickle cell disease through comprehensive, compassionate, and innovative integrative holistic services, education, and advocacy. The organization provides direct care and support services to individuals with SCD, ranging from newborns to adults, including holistic and hematology care, education and counseling, support services, and advocacy. Georgia has the nation's fourth-largest sickle cell population.

Key Strategic Focus

Core Objectives

To monitor Sickle Cell occurrences.

To advocate and advance knowledge.

To support research that improves treatment or seeks a cure.

To improve the quality of life for those battling sickle cell disease.

Specific Areas of Specialization

Holistic and Hematology Care: Providing comprehensive medical services tailored to the needs of individuals with SCD.

Education and Counseling: Offering programs to educate patients and families about SCD and providing counseling services.

Support Services: Delivering resources such as food assistance, housing support, and access to medical supplies.

Advocacy: Engaging in legislative efforts to improve healthcare access and support for individuals with chronic health conditions, including SCD.

Key Technologies Utilized

SCFG employs a range of technologies to support its mission, including:

Mobile Laboratory: Facilitating in-person appointments and testing services.

Clinical Laboratory: Providing comprehensive testing options for individuals living with sickle cell disease.

Primary Markets or Conditions Targeted

SCFG primarily serves individuals and families affected by sickle cell disease in Georgia, addressing the needs of the state's fourth-largest sickle cell population.

Financials and Funding

Funding History

SCFG has secured significant funding to support its initiatives, including:

State and Federal Grants: Over $5 million secured to support education, services, and research.

Corporate Sponsorships: Partnerships with organizations such as Novo Nordisk to advance research and provide innovative treatment options.

Recent Funding Rounds

Specific details regarding recent funding rounds are not publicly disclosed.

Notable Investors

SCFG has received support from various entities, including:

Novo Nordisk: A global healthcare company committed to changing outcomes for people living with sickle cell disease.

Intended Utilization of Capital

The funds are utilized to:

Expand and enhance programs and services for individuals with sickle cell disease.

Support research initiatives aimed at improving treatment and seeking a cure.

Advocate for better resources and policies for the sickle cell community.

Pipeline Development

As a nonprofit organization, SCFG does not have a product pipeline. However, it is involved in various initiatives to support individuals with sickle cell disease, including:

Sickle Cell Sanctuary Wellness Center: Celebrated its first anniversary in June 2025, offering holistic care services to individuals with sickle cell disease.

Legislative and Policy Conference: Hosted its inaugural conference in October 2025 to explore critical legislation and policy developments affecting healthcare access for individuals with chronic health conditions, including SCD.

Technological Platform and Innovation

Proprietary Technologies

Mobile Laboratory: Enables in-person appointments and testing services.

Clinical Laboratory: Provides comprehensive testing options for individuals living with sickle cell disease.

Significant Scientific Methods

Holistic Care Approach: Integrates traditional medical care with wellness therapies such as massage, yoga, and nutritional counseling.

AI-Driven Capabilities

Specific AI-driven capabilities are not publicly disclosed.

Leadership Team

Executive Director

Name: Tabatha McGee

Professional Background: A native of Georgia, McGee began her professional career serving in the U.S. Army, followed by a tenure at Xerox. She later founded Complete Vital Solutions, LLC, as a network engineer. McGee joined SCFG as a volunteer, eventually becoming Executive Director in October 2021.

Key Contributions: Established the Sickle Cell Sanctuary, secured over $5 million in grants, and expanded the organization's staff by 50% over three years.

Competitor Profile

Market Insights and Dynamics

The nonprofit sector addressing sickle cell disease in Georgia includes organizations such as MTS Sickle Cell Foundation, Inc., which focuses on increasing public awareness and providing support to families affected by SCD.

Competitor Analysis

MTS Sickle Cell Foundation, Inc.: Established in 2015, this organization aims to increase public awareness of sickle cell disease through education, research, and family support initiatives.

Strategic Collaborations and Partnerships

SCFG has formed strategic partnerships with healthcare institutions such as Grady Hospital and Emory Hospital to enhance care for individuals with sickle cell disease.

Operational Insights

SCFG differentiates itself through its holistic care approach, integrating traditional medical services with wellness therapies, and its comprehensive support services, including a mobile laboratory and clinical laboratory.

Strategic Opportunities and Future Directions

SCFG continues to expand its services, advocate for policy changes, and collaborate with healthcare providers to improve outcomes for individuals with sickle cell disease.